- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +250 more
- Locations
-
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Stage II Chronic Lymphocytic Leukemia
Explore clinical trials studying Stage II Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.
24 public trials
0 recruiting studies
Stage II Chronic Lymphocytic Leukemia trial results
Completed
Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
NCT01093586
- Conditions
- Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +141 more
- Locations
-
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT01024010
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +23 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
- Duke University Medical Center Durham, North Carolina, United States
NCT01789255
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +176 more
- Locations
-
- University of Michigan University Hospital Ann Arbor, Michigan, United States
NCT01053494
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Amyloidosis, +170 more
- Locations
-
- Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
NCT00476047
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00112593
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +281 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
NCT00098670
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +18 more
- Locations
-
- Cancer and Leukemia Group B Chicago, Illinois, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States
NCT00058227
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +71 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00003620
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +19 more
- Locations
-
- Cancer and Leukemia Group B Chicago, Illinois, United States